Contact Us

Open Clinical Trials at Colorado Urology 

Prostate Cancer
  • Dendreon study PROVENT — Prostate Cancer Dendreon Pharmaceuticals LLC – A Randomized Phase 3, Open-label trial of Sipuleucel-T administered to patients on active surveillance for newly diagnosed prostate cancer.
  • Advantagene Prostate Cancer — A randomized controlled trial of ProstAtak® as adjuvant to up-front radiation therapy for localized prostate cancer.
  • Advantagene Prostate Cancer — A randomized controlled trial of AdV-tk + Valacyclovir administered during active surveillance for newly diagnosed prostate cancer.
  • Veru — Hot flash study – A randomized, double-blind,placebo-controlled, dose finding Phase 2 study comparing oral daily dosing of VERU-944 after a week of loading (daily dosing) with placebo to ameliorate the vasomotor symptoms resulting from androgen deprivation therapy in men with advanced prostate cancer.
Low Testosterone
  • TRAVERSE study — Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men
For information about clinical trials, please call 303-996-9649. 
Contact Us

Appointments & Information

*If this is an emergency, please call 911 immediately.

Please provide your email address and phone number and a Colorado Urology representative will contact you shortly to assist with your question or issue.

Monday–Friday, 8:30 a.m. to 4:30 p.m.

  • This field is for validation purposes and should be left unchanged.

Contact Us